A couple of weeks ago I drew attention to a piece in Lockdown Sceptics called "Thousands of Women Suffering Period Problems Following Covid Vaccination", which was based on an original article in The Sunday Times called, "4,000 women report period problems after Covid jab", and which noted that "Britain’s medicines regulator has received reports from almost 4000 women, mostly aged between 30 and 49, who have suffered period problems after taking a Covid vaccine."
At the time, I posed the following question: Did that have any connection to the Pfizer information gained via FOI request from the Japanese regulatory agency? That information apparently shows that Pfizer's vaccine trials on Wistar Hannover Rats resulted in an unexpected accumulation of lipid nanoparticles (LNPs) in the ovaries of female rats. (A PDF of that study can be accessed via this page at TrialSite News.)
Since then, two MDs have independently answered my question.
1) Dr Mobeen Syed (Dr Been) pointed out in this video ("SARS-COV-2 Spikes in Ovaries from Pfizer-BioNTech Vaccine? - YouTube") that the remit of the study was to investigate the biodistribution of lipid nanoparticles, NOT the mRNA. (It is, of course, the mRNA that codes for the spike proteins, not the LNPs, which are just the vehicles for the mRNA.)
2) Dr Robert Malone—often credited as the inventor of mRNA technology—has confirmed in an interview for TrialSite News that the accumulation of viral mRNA in the ovaries of these test rodents is far lower than the accumulation of LNPs.
It would therefore seem that there is little reason to be alarmed by this study in particular.